Hubei Goto Biopharm Co Ltd
SZSE:300966
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hubei Goto Biopharm Co Ltd
Inventory
Hubei Goto Biopharm Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hubei Goto Biopharm Co Ltd
SZSE:300966
|
Inventory
¥384.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Inventory
¥4.3B
|
CAGR 3-Years
30%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Inventory
¥1.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Inventory
¥661.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Inventory
¥931.6m
|
CAGR 3-Years
40%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Inventory
¥63m
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hubei Goto Biopharm Co Ltd
Glance View
Hubei Goto Biopharm Co., Ltd. engages in the research, development, production, and sale of steroidal drug raw materials. The company is headquartered in Xiangfan, Hubei and currently employs 481 full-time employees. The company went IPO on 2021-04-09. The firm's main products are starting materials and intermediates required for the production of steroid drugs. The starting materials refer to the products obtained from the conversion of plant sterols through biological fermentation technology. These products are important raw materials for downstream pharmaceutical intermediates and active pharmaceutical ingredient manufacturers and belong to the upstream products in the steroid drug industry chain. The firm's intermediate products mainly include sex hormone intermediates, progesterone intermediates, corticosteroid intermediates and other products.
See Also
What is Hubei Goto Biopharm Co Ltd's Inventory?
Inventory
384.8m
CNY
Based on the financial report for Dec 31, 2024, Hubei Goto Biopharm Co Ltd's Inventory amounts to 384.8m CNY.
What is Hubei Goto Biopharm Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
10%
Over the last year, the Inventory growth was -3%. The average annual Inventory growth rates for Hubei Goto Biopharm Co Ltd have been 1% over the past three years , 10% over the past five years .
